Bone Biologics Corp
BBLG
Market Cap$3.19M
Close$
$2.19
64.6% downside
Current Fair Value
64.6% downsideOvervalued by 64.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.19 Million |
|---|---|
| Enterprise Value | $440,464.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-34.03 |
| Beta | 0.7 |
| Outstanding Shares | 1,168,423 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.39 |
|---|---|
| PEG | -2.25 |
| Price to Sales | - |
| Price to Book Ratio | 3.1 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.1 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bone Biologics Corp
2 employees